Logo image of BCOV

BRIGHTCOVE (BCOV) Stock Fundamental Analysis

USA - NASDAQ:BCOV - US10921T1016 - Common Stock

4.45 USD
+0.01 (+0.23%)
Last: 2/3/2025, 8:15:51 PM
4.45 USD
0 (0%)
After Hours: 2/3/2025, 8:15:51 PM
Fundamental Rating

3

Overall BCOV gets a fundamental rating of 3 out of 10. We evaluated BCOV against 86 industry peers in the IT Services industry. The financial health of BCOV is average, but there are quite some concerns on its profitability. BCOV is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

BCOV had positive earnings in the past year.
In the past year BCOV had a positive cash flow from operations.
In the past 5 years BCOV reported 4 times negative net income.
BCOV had a positive operating cash flow in each of the past 5 years.
BCOV Yearly Net Income VS EBIT VS OCF VS FCFBCOV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M

1.2 Ratios

BCOV's Return On Assets of -4.34% is in line compared to the rest of the industry. BCOV outperforms 40.51% of its industry peers.
BCOV has a Return On Equity (-9.58%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROIC N/A
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
BCOV Yearly ROA, ROE, ROICBCOV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

BCOV has a Gross Margin of 61.60%. This is amongst the best in the industry. BCOV outperforms 81.01% of its industry peers.
In the last couple of years the Gross Margin of BCOV has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for BCOV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
BCOV Yearly Profit, Operating, Gross MarginsBCOV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

BCOV does not have a ROIC to compare to the WACC, probably because it is not profitable.
BCOV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BCOV has been increased compared to 5 years ago.
BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BCOV Yearly Shares OutstandingBCOV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
BCOV Yearly Total Debt VS Total AssetsBCOV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

BCOV has an Altman-Z score of 0.08. This is a bad value and indicates that BCOV is not financially healthy and even has some risk of bankruptcy.
BCOV's Altman-Z score of 0.08 is on the low side compared to the rest of the industry. BCOV is outperformed by 83.54% of its industry peers.
BCOV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 0.08
ROIC/WACCN/A
WACC10.73%
BCOV Yearly LT Debt VS Equity VS FCFBCOV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.75 indicates that BCOV may have some problems paying its short term obligations.
BCOV's Current ratio of 0.75 is on the low side compared to the rest of the industry. BCOV is outperformed by 88.61% of its industry peers.
A Quick Ratio of 0.75 indicates that BCOV may have some problems paying its short term obligations.
BCOV's Quick ratio of 0.75 is on the low side compared to the rest of the industry. BCOV is outperformed by 88.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
BCOV Yearly Current Assets VS Current LiabilitesBCOV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 145.45% over the past year.
The Revenue has decreased by -0.22% in the past year.
Measured over the past years, BCOV shows a small growth in Revenue. The Revenue has been growing by 4.07% on average per year.
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%

3.2 Future

The Earnings Per Share is expected to grow by 64.74% on average over the next years. This is a very strong growth
Based on estimates for the next years, BCOV will show a small growth in Revenue. The Revenue will grow by 0.01% on average per year.
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BCOV Yearly Revenue VS EstimatesBCOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
BCOV Yearly EPS VS EstimatesBCOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 0 0.2 -0.2 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 89.00, which means the current valuation is very expensive for BCOV.
The rest of the industry has a similar Price/Earnings ratio as BCOV.
When comparing the Price/Earnings ratio of BCOV to the average of the S&P500 Index (27.77), we can say BCOV is valued expensively.
BCOV is valuated quite expensively with a Price/Forward Earnings ratio of 124.65.
BCOV's Price/Forward Earnings is on the same level as the industry average.
BCOV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.23.
Industry RankSector Rank
PE 89
Fwd PE 124.65
BCOV Price Earnings VS Forward Price EarningsBCOV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BCOV.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BCOV is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 51.96
EV/EBITDA 23.8
BCOV Per share dataBCOV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

BCOV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BCOV's earnings are expected to grow with 64.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)N/A
EPS Next 2Y64.74%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BCOV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIGHTCOVE

NASDAQ:BCOV (2/3/2025, 8:15:51 PM)

After market: 4.45 0 (0%)

4.45

+0.01 (+0.23%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-20 2025-02-20/amc
Inst Owners70.58%
Inst Owner Change0%
Ins Owners5.23%
Ins Owner Change0%
Market Cap201.05M
Analysts45.71
Price Target4.54 (2.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)100%
Min EPS beat(2)56.43%
Max EPS beat(2)143.57%
EPS beat(4)4
Avg EPS beat(4)114.38%
Min EPS beat(4)56.43%
Max EPS beat(4)161.44%
EPS beat(8)6
Avg EPS beat(8)77.66%
EPS beat(12)10
Avg EPS beat(12)100.79%
EPS beat(16)14
Avg EPS beat(16)114.38%
Revenue beat(2)2
Avg Revenue beat(2)0.71%
Min Revenue beat(2)0.56%
Max Revenue beat(2)0.87%
Revenue beat(4)2
Avg Revenue beat(4)-0.15%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.87%
Revenue beat(8)2
Avg Revenue beat(8)-1%
Revenue beat(12)6
Avg Revenue beat(12)-0.14%
Revenue beat(16)10
Avg Revenue beat(16)0.35%
PT rev (1m)0%
PT rev (3m)14.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)50%
EPS NY rev (1m)N/A
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 89
Fwd PE 124.65
P/S 1.01
P/FCF 51.96
P/OCF 14.73
P/B 2.11
P/tB 11.84
EV/EBITDA 23.8
EPS(TTM)0.05
EY1.12%
EPS(NY)0.04
Fwd EY0.8%
FCF(TTM)0.09
FCFY1.92%
OCF(TTM)0.3
OCFY6.79%
SpS4.42
BVpS2.11
TBVpS0.38
PEG (NY)0.89
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.34%
ROE -9.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.6%
FCFM 1.94%
ROA(3y)-4.02%
ROA(5y)-5.56%
ROE(3y)-9.19%
ROE(5y)-12.88%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.06%
GM growth 5Y0.65%
F-Score7
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 50.16%
Cap/Sales 4.89%
Interest Coverage N/A
Cash Conversion 186.6%
Profit Quality N/A
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 0.08
F-Score7
WACC10.73%
ROIC/WACCN/A
Cap/Depr(3y)143.44%
Cap/Depr(5y)123.4%
Cap/Sales(3y)7.87%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)145.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-60%
EPS Next Y100%
EPS Next 2Y64.74%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y0.64%
Revenue growth 5Y4.07%
Sales Q2Q%-2.02%
Revenue Next Year-1.51%
Revenue Next 2Y0.01%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year979.3%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y4.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.43%
OCF growth 3Y-40.43%
OCF growth 5Y12.05%